Stifel Financial Corp Acquires 9,582 Shares of The Clorox Company (NYSE:CLX)

Stifel Financial Corp increased its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 0.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,344,408 shares of the company's stock after acquiring an additional 9,582 shares during the quarter. Stifel Financial Corp owned approximately 1.89% of Clorox worth $380,761,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of CLX. State of Tennessee Department of Treasury increased its holdings in Clorox by 69.8% in the 4th quarter. State of Tennessee Department of Treasury now owns 38,455 shares of the company's stock worth $6,245,000 after buying an additional 15,810 shares in the last quarter. Tower Research Capital LLC TRC increased its position in Clorox by 100.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 11,377 shares of the company's stock valued at $1,848,000 after acquiring an additional 5,710 shares during the last quarter. Transce3nd LLC bought a new stake in shares of Clorox during the 4th quarter worth approximately $77,000. MetLife Investment Management LLC boosted its position in Clorox by 1.0% during the 4th quarter. MetLife Investment Management LLC now owns 38,236 shares of the company's stock valued at $6,210,000 after acquiring an additional 375 shares in the last quarter. Finally, Ossiam boosted its stake in Clorox by 438.4% in the fourth quarter. Ossiam now owns 83,454 shares of the company's stock valued at $13,554,000 after acquiring an additional 67,953 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Stock Performance

Shares of NYSE:CLX traded down $1.61 on Thursday, hitting $137.50. 1,221,111 shares of the company were exchanged, compared to its average volume of 1,303,239. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The company's 50 day moving average price is $146.01 and its two-hundred day moving average price is $155.99. The firm has a market capitalization of $16.94 billion, a price-to-earnings ratio of 37.57, a PEG ratio of 2.62 and a beta of 0.61.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the company earned $2.16 earnings per share. Research analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.55%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox's dividend payout ratio is currently 133.33%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on CLX shares. JPMorgan Chase & Co. decreased their target price on Clorox from $173.00 to $151.00 and set a "neutral" rating on the stock in a research report on Friday, April 11th. Evercore ISI upped their price target on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Wells Fargo & Company decreased their target price on Clorox from $155.00 to $145.00 and set an "equal weight" rating for the company in a research note on Wednesday, April 16th. DA Davidson lowered their target price on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 5th. Finally, Barclays cut their price objective on shares of Clorox from $139.00 to $134.00 and set an "underweight" rating for the company in a research report on Friday, April 11th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Clorox has an average rating of "Hold" and an average price target of $153.83.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.